期刊
AIDS RESEARCH AND HUMAN RETROVIRUSES
卷 34, 期 9, 页码 790-793出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/aid.2018.0114
关键词
HIV-1; broadly neutralizing antibody; PGDM1400; prophylactic agent; human immune system mouse
资金
- Veni from the Netherlands Organization for Scientific Research (NWO) [016171112]
- Vici from the Netherlands Organization for Scientific Research (NWO) [91818627]
- American Foundation for AIDS Research (amfAR) Krim Fellowship [109514-61-RKVA]
- 2017 AMC Fellowship
- Eurostar grant ResistAids [E!10239]
Broadly neutralizing antibodies (bNAbs) such as PGDM1400 show promise as prophylactic and therapeutic agents against HIV-1. Human immune system mice were passively immunized with different doses of PGDM1400 and challenged 24h later with a high dose of HIV-1(JRCSF). We found that PGDM1400 provided protection against HIV-1 challenge in a concentration dependent manner and that the protective concentration in blood was similar to 75-fold higher than the in vitro 50% inhibitory concentration. The results demonstrate that PGDM1400 might be a promising component of strategies to prevent HIV-1 infection and provide support for the pursuit of vaccines that induce PGDM1400-like bNAbs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据